Astera Labs (NASDAQ:ALAB) Shares Up 2.4% – Here’s What Happened

Shares of Astera Labs, Inc. (NASDAQ:ALAB – Get Free Report) shot up 2.4% during mid-day trading on Wednesday. The stock traded as high as $222.01 and last traded at $216.75. 4,541,550 shares changed hands during mid-day trading, a decline of 12% from the average session volume of 5,136,489 shares. The stock had previously closed at $211.60.

Top Astera Labs Stories

Here are a few of the latest stories about ALAB:

  • Positive Sentiment: Astera expanded its partnership with Hyve Solutions, integrating its Orion Compute Board, Fabric Tray and Link Board into Hyve’s Apex platform. The pre-validated designs aim to speed AI-rack integration for enterprise data centers and accommodate different accelerators and CPUs, potentially broadening Astera’s opportunity as AI inference deployments grow. Article: How Does Astera Labs’ New AI Infrastructure Partnership Change Its Enterprise Opportunity?
  • Neutral Sentiment: General Counsel Philip Mazzara sold 4,380 shares, but the filing says the sale was to cover tax withholding on vested equity awards. He retained 92,190 shares, making this less indicative of a change in his view of the company. SEC Form 4 filing
  • Negative Sentiment: Reports describe continued share-price pressure, ETF net selling and analyst target resets despite strong growth. Comparisons with Amphenol also emphasize ALAB’s higher valuation, which may leave the stock vulnerable to further selling if expectations cool. Article: Why Is Astera Labs Stock Falling Again? Article: ETFs Are Net Sellers of Astera Labs

Analyst Ratings Changes

A number of research analysts have issued reports on the company. Morgan Stanley upped their price objective on Astera Labs from $382.00 to $389.00 and gave the company an “overweight” rating in a research note on Wednesday, November 4th. Needham & Company LLC lowered their target price on Astera Labs from $425.00 to $300.00 and set a “buy” rating on the stock in a research note on Wednesday, November 4th. UBS Group lowered their target price on Astera Labs from $300.00 to $290.00 and set a “neutral” rating on the stock in a research note on Wednesday, November 4th. Northland Securities raised shares of Astera Labs from a “market perform” rating to an “outperform” rating and set a $315.00 price target on the stock in a report on Wednesday, November 4th. Finally, TD Cowen reduced their price target on shares of Astera Labs from $300.00 to $225.00 and set a “hold” rating for the company in a research report on Wednesday, November 4th. Thirteen equities research analysts have rated the stock with a Buy rating and ten have given a Hold rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $320.85.

Check Out Our Latest Stock Report on Astera Labs

Astera Labs Stock Up 2.4%

The firm has a 50 day moving average of $290.56 and a 200 day moving average of $257.51. The firm has a market cap of $37.88 billion, a PE ratio of 86.35 and a beta of 3.85.

Astera Labs (NASDAQ:ALAB – Get Free Report) last released its earnings results on Tuesday, November 3rd. The company reported $1.32 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.19 by $0.13. Astera Labs had a return on equity of 25.35% and a net margin of 29.64%. The business had revenue of $584.90 million during the quarter, compared to the consensus estimate of $550.78 million. During the same period last year, the business posted $0.49 earnings per share. The business’s revenue for the quarter was up 153.6% on a year-over-year basis. On average, research analysts anticipate that Astera Labs, Inc. will post 2.99 EPS for the current year.

Insider Activity

In related news, General Counsel Philip Mazzara sold 4,380 shares of Astera Labs stock in a transaction dated Monday, November 16th. The stock was sold at an average price of $206.62, for a total value of $904,995.60. Following the completion of the sale, the general counsel owned 92,190 shares of the company’s stock, valued at approximately $19,048,297.80. This trade represents a 4.54% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Manuel Alba sold 183,000 shares of the business’s stock in a transaction dated Tuesday, September 1st. The shares were sold at an average price of $280.13, for a total value of $51,263,790.00. Following the completion of the sale, the director owned 253,863 shares in the company, valued at $71,114,642.19. This represents a 41.89% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last three months, insiders have sold 417,055 shares of company stock worth $102,656,117. 10.40% of the stock is owned by company insiders.

Hedge Funds Weigh In On Astera Labs

Several large investors have recently modified their holdings of the business. Liontrust Investment Partners LLP boosted its holdings in Astera Labs by 117.7% in the 3rd quarter. Liontrust Investment Partners LLP now owns 67,504 shares of the company’s stock worth $24,029,000 after buying an additional 36,490 shares during the period. Zacks Investment Management purchased a new position in Astera Labs in the 3rd quarter valued at approximately $3,013,000. Kentucky Retirement Systems Insurance Trust Fund purchased a new position in Astera Labs in the 3rd quarter valued at approximately $1,389,000. Kentucky Retirement Systems bought a new stake in Astera Labs during the 3rd quarter valued at $3,431,000. Finally, Algert Global LLC raised its holdings in Astera Labs by 1,447.7% during the 3rd quarter. Algert Global LLC now owns 9,936 shares of the company’s stock valued at $3,537,000 after acquiring an additional 9,294 shares during the period. Hedge funds and other institutional investors own 60.47% of the company’s stock.

About Astera Labs

(Get Free Report)

Astera Labs, Inc. is a fabless semiconductor company that develops connectivity solutions for cloud and artificial intelligence infrastructure. Its products are designed to help move data among processors, accelerators, memory and other components in high-performance computing systems. The company’s portfolio includes Aries PCIe and CXL retimers, Taurus Ethernet smart cable modules, Scorpio fabric switches and Leo CXL memory connectivity controllers. Astera Labs also offers software tools to help customers configure and monitor its connectivity products.

Featured Stories

Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.